Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-Use Antimalarial Monoclonal Antibodies for Post-Discharge Malaria Prevention in Children With Severe Anaemia or Severe Malaria in Kenya
NCT07082205Phase 3Active, not recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- May 2025
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of L9LS in malaria, sponsored by Liverpool School of Tropical Medicine. Started May 2025; status: active, not recruiting.
02
Drugs
L9LS
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07082205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07082205.